TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nantes University Hospital
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Indiana University
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Utah
Institute of Hematology & Blood Diseases Hospital, China
Fred Hutchinson Cancer Center
University of Southern California
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Montefiore Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.